| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Pancreatic Polypeptide : 39438
Test CodePANPOQ or 39438
CPT Codes
83520
Instructions
Overnight fasting is preferred.
Lavender (EDTA) tube.
Lavender (EDTA) tube.
Transport Container
Centrifuge lavender top tube and aliquot 0.5 mL plasma (Min: 0.3 mL) into a standard transport tube.
Transport Temperature
Refrigerated.
Specimen Stability
Ambient: 5 days; Refrigerated: 7 days; Frozen: 1 year
Methodology
Electrochemiluminescence
Setup Schedule
Wednesday
Report Available
4-8 days (From receipt at performing laboratory)
Limitations
This test is performed using and electrochemiluminescent method. Values obtained from different assay methods cannot be used interchangeable. pancreatic Polypeptide levels, regardless of value, should not be interpretedas absolute evidence of the presence or absence of disease.
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute, San Juan Capistrano. It has not been cleared or approved by FDS. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute, San Juan Capistrano. It has not been cleared or approved by FDS. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range
Effective 4-13-2020
<4 years: Not established
4-17 years: 92-752 pg/mL
> or= 18 years: 56-480 pg/mL
<4 years: Not established
4-17 years: 92-752 pg/mL
> or= 18 years: 56-480 pg/mL
Clinical Significance
Detection of Pancreatic Polypeptide is used in the assessment of pancreatic tumor burden and to assist in the early diagnosis of pancreatic tumors. The measurement of pancreatic polypeptide is also used to monitor pancreatic carcinoma therapy and to predict the recurrence of pancreatic tumors.
Performing Laboratory
Quest Diagnostics
